Unusual 11 Mid-Day Movers 11/23: ABIO, SEED, FNET, CDTI Higher; ...

Courtesy StreetInsider.com News Articles  Mon, 11/23/2009 - 11:55

ARCA Biopharma, Inc. (NASDAQ: ABIO) 89.3% HIGHER; today announced that the U.S. FDA has designated as a Fast Track development program the investigation of Gencaro, the Company's investigational, pharmacologically unique beta-blocker and mild vasodilator, for the reduction of cardiovascular mortality and cardiovascular hospitalizations in a genotype-defined heart failure population.

The Company intends to submit a study protocol for review under the FDA's Special Protocol Assessment process for the design of a clinical trial to assess the safety and efficacy of...


 

Related items

Morning Movers 11/23: ABIO, SEED, FIF, FNET, DDRX,...
ARCA Biopharma, Inc. (NASDAQ: ABIO) 47.6% HIGHER; today announced that the U.S. FDA has designated as a Fast Track development program the investigation of Gencaro, the Company's...

Studies: Drug, device help treat heart failure
Millions of people with mild or moderate heart failure got good news Sunday, with studies showing a Pfizer drug and a device from Medtronic can boost survival and cut trips to the hospital by...

Rochester-led study leads to recommendation for use...
(University of Rochester Medical Center) The FDA's Circulatory System Devices Panel recommended that the cardiac resynchronization therapy defibrillator (CRT-D), developed by Boston...

HP No. 45 Black Inkjet Print Cartridge (51645A)
Black Ink Cartridge for Hewlett Packard printers and other designated machines

Green Laser Pointer II
No, it's not red - it's green Okay, just about everyone has a red laser pointer. Heck, we even sell a fine one here at ThinkGeek. But, we're pretty sure you want to be a superior geek - and...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
CAPTCHA
We apologize for the inconvenience. Please help fight spam.
business.marc8.com